期刊
CANCER LETTERS
卷 394, 期 -, 页码 22-32出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2017.02.011
关键词
Hepatitis B virus X protein; High mobility group box 1; Calmodulin dependent protein kinase; Hepatocellular carcinoma; Metastasis
类别
资金
- National Natural Science Foundation of China [81370061, 81572896, 81521091]
- Personalized Medicines-Molecular Signature based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020102]
Hepatitis B virus X protein (HBx) plays an important role in the progression of hepatocellular carcinoma. Here we reported that overexpression of HBx in hepatocellular carcinoma (HCC) cells could induce the secretion of high-mobility group box 1 (HMGB1) to promote invasion and metastasis of HCC in an autocrine/paracrine manner. HBx triggered an increase of cytoplasmic calcium and activated CAMKK/CAMKIV pathway, leading to subsequent translocation and release of HMGB1. HMGB1 neutralizing antibody, as well as calcium chelator or inhibitors of CAMKK/CAMKIV, could remarkably reduce invasion and metastasis of HCC cells in vitro and in a murine HCC metastasis model in vivo. Furthermore, the level of HMGB1 in patient serum and tumor tissues was positively correlated with HBV DNA load. We demonstrate an inverse relationship between HMGB1 in tumor cytoplasm and overall prognosis of HCC patients. Conclusion: HBx promotes the progression of HCC through translocation and secretion of HMGB1 from tumor cells via calcium dependent cascades. These data indicates that HMGB1 could serve as a novel prognostic biomarker and potential therapeutic target for HBV-related HCC. (C) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据